Casomorphin
|
|
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (August 2008) |
Casomorphins are peptides, i.e., protein fragments, derived from the digestion of milk protein casein. The distinguishing characteristic of casomorphins is that they have an opioid effect.[1]
The most important casomorphins from bovine milk are those released from the digestion of β-casein into β-casomorphins, sometimes denoted as BCM followed by a numeral indicating the number of amino acids in the sequence. In cattle, the amount of β-casein - and, hence, the potential release of β-casomorphins - varies between species and breeds. Typically, β-casein comprises about one-third of the casein in milk, or about 12 grams per liter of milk. However, there are at least 13 different variants of the β-casein protein in cattle population, with any one cow producing milk that will contain either one or two of these 13 variants. β-casomorphins are found in cheeses made from bovine milk; their concentrations are higher in mould cheeses (e.g. Brie, Rokpol) than in semi-hard cheeses (e.g. Edam, Gouda and Kasztelan) [1].
Each variant fits into one of two main categories known as A1 and A2. In cattle, A1-type β-caseins have the amino acid histidine at position 67, whereas the A2-type β-caseins have the amino acid proline at position 67. Laboratory experiments show that the casomorphin known as BCM7 is released only from the A1-type β-caseins.[2] The potential release of BCM7 is about 0.4 grams per litre of milk (assuming as above that there are 12g of β-casein per litre).
Human digestion may break down casomorphins into inactive dipeptides by the enzyme dipeptidyl peptidase-4.[3][4] This enzyme is found in the digestive tract and in some endocrine cells.
There is also the potential for release of casomorphins from human milk. However, human BCM7 (Tyr-Pro-Phe-Val-Glu-Pro-Ile) differs from the bovine form (Tyr-Pro-Phe-Pro-Gly-Pro-Ile) at two amino acid positions.[citation needed]
Scientific understanding of the biochemistry and pharmacology of casomorphins is incomplete. A recent scientific review is provided by Kaminski et al. (2007).[5]
Contents |
[edit] Health
Casein has been documented to break down in the stomach to produce the peptide casomorphin, an opioid that acts as a histamine releaser.[6]
Diets that eliminate foods containing casein are promoted at conferences for parents of children with ASD, and some books, web sites, and discussion groups contain testimonials describing benefits in autism-related symptoms, notably social engagement and verbal skills.[7] Studies supporting these claims have had significant flaws, so the data is inadequate to guide treatment recommendations.[7] These ideas were tested using sensitive and specific assays based on a combination of HPLC and mass spectrometry, but these peptides cannot be detected in autistic children's urine.[8][9] The previous reports of these peptides used less specific assays and were strongly criticised as using unreliable methods that were prone to false positive results.[10] However, proponents continue to argue that these peptides are implicated in a number of medical conditions, including diabetes, heart disease, and symptoms of autism and schizophrenia.[11]
[edit] Some known casomorphins
[edit] β-Casomorphin 1-3
- Structure: H-Tyr-Pro-Phe-OH
- Chemical formula: C23H27N3O5
- Molecular weight: 425.48 g/mol
[edit] Bovine β-casomorphin 1-4
- Structure: H-Tyr-Pro-Phe-Pro-OH
- Chemical formula:
- Molecular weight: 522.61 g/mol
[edit] Bovine β-casomorphin 1-4, amide
- Structure: H-Tyr-Pro-Phe-Pro-NH2
- Chemical formula: C28H39N5O7
- Molecular weight: 557.64 g/mol
Also known as morphiceptin
[edit] Bovine β-casomorphin 5
- Structure: H-Tyr-Pro-Phe-Pro-Gly-OH
- Chemical formula: C30H37N5O7
- Molecular weight: 594.66 g/mol
[edit] Bovine β-casomorphin 7
- Structure: H-Tyr-Pro-Phe-Pro-Gly-Pro-Ile-OH
- Chemical formula: C41H55N7O9
- Molecular weight: 789.9 g/mol
[edit] Bovine β-casomorphin 8
- Structure: H-Tyr-Pro-Phe-Pro-Gly-Pro-Ile-Pro-OH
- Chemical formula: C46H62N8O10
- Molecular weight: 887.00 g/mol
(Note: There is also a form of bovine β-Casomorphin 8 that has histidine instead of proline in position 8, depending on whether it is derived from A1 or A2 beta-casein.)
[edit] References
- ^ a b http://www.sciencedirect.com/science/article/pii/S0958694608001970
- ^ Jinsmaa Y, Yoshikawa M, 1999; "Enzymatic release of neocasomorphin and beta-casomorphinfrom bovine beta-casein"; Peptides 20:957-962
- ^ Püschel G, Mentlein R, Heymann E (1982). "Isolation and characterization of dipeptidyl peptidase IV from human placenta". Eur J Biochem 126 (2): 359–365. doi:10.1111/j.1432-1033.1982.tb06788.x. PMID 6751824.
- ^ Converse PJ, Hamosh A, McKusick VA (2005). DIPEPTIDYL PEPTIDASE IV; DPP4. Online Mendelian Inheritance in Man.
- ^ Stanislaw Kaminski, Anna Cielinska, Elzbieta Kostyra (2007). "Polymorphism of bovine beta-casein and its potential effect on health". Journal of Applied Genetics 48 (3): 189–198. doi:10.1007/BF03195213. PMID 17666771.
- ^ Kurek M, Przybilla B, Hermann K, Ring J (1992). "A naturally occurring opioid peptide from cow's milk, beta-casomorphine-7, is a direct histamine releaser in man". Int Arch Allergy Immunol 97 (2): 115–120. doi:10.1159/000063326. PMID 1374738.
- ^ a b Christison GW, Ivany K (2006). "Elimination diets in autism spectrum disorders: any wheat amidst the chaff?". J Dev Behav Pediatr 27 (2 Suppl 2): S162–71. doi:10.1097/00004703-200604002-00015. PMID 16685183.
- ^ Dettmer K, Hanna D, Whetstone P, Hansen R, Hammock BD (August 2007). "Autism and urinary exogenous neuropeptides: development of an on-line SPE-HPLC-tandem mass spectrometry method to test the opioid excess theory". Anal Bioanal Chem 388 (8): 1643–51. doi:10.1007/s00216-007-1301-4. PMID 17520243.
- ^ Cass H, Gringras P, March J, et al. (September 2008). "Absence of urinary opioid peptides in children with autism". Arch. Dis. Child. 93 (9): 745–50. doi:10.1136/adc.2006.114389. PMID 18337276.
- ^ Hunter LC, O'Hare A, Herron WJ, Fisher LA, Jones GE (February 2003). "Opioid peptides and dipeptidyl peptidase in autism". Dev Med Child Neurol 45 (2): 121–8. doi:10.1111/j.1469-8749.2003.tb00915.x. PMID 12578238.
- ^ http://aut.sagepub.com/cgi/content/abstract/3/1/85
[edit] External links
- Review of the potential health impact of β-casomorphins and related peptides European Food Safety Agency, Scientific Report (2009) 231, 1-107